Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Antiretroviral Treatment and Predictors in Subjects With Extremely Low HIV-1 Reservoir: Optimization of New Cure Strategies

NCT02972931 is registered in ClinicalTrials.gov with IrsiCaixa as lead sponsor.

NCT NCT02972931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02972931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Antiretroviral Treatment and Predictors in Subjects With Extremely Low HIV-1 Reservoir: Optimization of New Cure Strategies
Lead sponsor
IrsiCaixa
Phase
Observational
Overall status
Completed
Start date
January 18, 2018
Completion date
June 20, 2019
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv